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Recent Advances In The Management Of
Nasopharyngeal Carcinoma
W I Wei,* MS, FRCSE, DLO, FACS
Department of Surgery
The University of Hong Kong
Summary
Developments in serology texts, imaging studies and endoscopic examinations contribute to early diagnosis
of nasopharyngeal carcinoma. The primary treatment modality is radiotherapy. When tumour recurs after
radiation, then surgical salvage contributes to a better prognosis. (HK Pract 1998;20:270-281)
Introduction
N a s o p h a r y n g e a l c a r c i n o m a
(NPC), the most frequent neoplasm in
the nasopharynx, is common among
the Chinese in Southeast Asia and
Hong Kong. The incidence ranges
from 18 to 30 per 100,000 population
and this has remained static in recent
decades.' NPC affects all age groups
with a peak incidence in the fifth
decade of l ife. When a pa t i en t
presents with early stage disease then
outcome is more favourable. Over the
years, advances have been achieved in
early diagnosis and in the accurate
evaluation of the extent of the tumour
enabling the administration of effective
treatment with fewer complications.
Signif icant progress has also been
made in therapy, particularly in the
treatment of recurrent disease in the
nasopharynx, and in the neck after
external radiotherapy.
Diagnosis
The early warning signs of NPC
are notoriously scanty. Patients may
have a "stuffy nose" with occasional
epistaxis. Or they may present with
serous otitis media as the tumour in the
nasopharynx affects Eustachian tube
function. A painless enlarged upper
cervical lymph node remains the
commonest presenting symptom. In an
endemic area, a h igh index of
awareness of the disease is important
to make the diagnosis at an early stage.
Serology
Epstein Barr virus (EBV) belongs
to the herpes virus family and in
different individuals it brings about
different pathology. It has been found
to be associated with infectious mono-
nucleosis, Burkitt 's lymphoma and
nasopharyngeal carcinoma. The EBV
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specific antigens can be grouped as
late antigens, early replicative antigens
and latent phase ant igens. The
antigens associated with NPC are viral
capsid antigen (VCA) which belongs
to the late antigen group and early
intracellular antigen (EA) of the early
replicative antigen group. In patients
suffering from NPC, high levels of IgA
against EA and VCA have been
detected2 and these can be used as
indicators for diagnosis.3 IgA anti EA
is a more specific test for NPC than
IgA anti VCA which is however, more
sensitive and these serological tests
have been used to screen high risk
groups to obtain an early diagnosis,
In a prospective study carried out
in a high risk region attempting to
diagnose subclinical NPC, both IgA
anti VCA and IgA ant i EA were
employed as initial screening tests.
For patients with elevated levels of
both IgAs, f l ex ib l e endoscopic
examination of the nasopharynx and
biopsy was performed. Among the
130 seropositive but asymptomatic
patients, seven were diagnosed to be
suffering from NPC.4 The level of the
antibodies to IgA anti EBV has also
been shown to be related to the stage
of disease which indirectly reflects
tumour burden.5 The level of IgA anti
VCA has been reported to decrease
after tumour eradication following
radiotherapy, its value in monitoring
for recurrent disease has not yet been
established.6
Endoscopic examination
Early NPC is usually located in
the fossa of Rosenmuller which is
medial to the medial crura of the
Eustachian tube. These early lesions
can only be detected with a thorough
examination of the nasopharynx and
this is difficult with a conventional
posterior rhinological mirror. The
nasopharynx may now be adequately
examined under anaesthesia with
either a rigid or flexible endoscope and
when a suspicious lesion is seen,
biopsy under direct vision is possible.
The rigid Hopkin rod endoscope gives
an excellent view of the nasopharynx
on the side of insertion. (Figure 1) It
does not have a suction channel and
biopsy forceps can only be inserted
alongside the endoscope.
The f l e x i b l e endoscope wi th
suction and biopsy channels is useful
for a detailed examination of the
nasopharynx. The scope may be
inserted through one nasal cavity and
tu rned to examine the opposite
nasopharynx behind the nasal septum.
(Figure 2) When a large tumour
blocks both nasal cavities or when
there are anatomical variations such as
a grossly deviated nasal septum, then
the flexible endoscope may be inserted
transorally and manipulated upwards
behind the soft palate to reach the
tumour in the nasopharynx (Figure 3).
Figure 1: Rigid endoscopic view of the nasopharynx, showing a
tumour (tm) and medial crura of Eustachian tube
(arrow)
(Continued on page 274)
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Figure 2: Right
Left
The mobile tip of the flexible endoscope
Flexible endoscope inserted through the right nostril
showing the right Eustachian tube opening (arrow)
and tumour (tm) of the contralateral nasopharynx
behind the posterior edge of the nasal septum.
(arrow heads)
Figure 3: Flexible endoscope inserted transorally and manipulated behind
the soft palate to see the tumour (arrow) at the roof of the
nasopharynx
As the size of the biopsy forceps is
limited by the diameter of the biopsy
channel of the scope, it is not easy to
obtain large tissue biopsies for
histological examination. When taking
a b i o p s y t h r o u g h the f l ex ib l e
endoscope, the mucosa should first be
broken with the forceps and then one
jaw of the forceps may be inserted into
the submucosa to obtain more tissue.7
Imaging techniques
Computed tomography (CT) is
now rou t ine ly employed for the
imaging of lesions in the nasopharynx.
It is useful to delineate soft tissue
swelling in the nasopharynx and thus
the extent of tumour. (Figure 4) CT
is also superior to convent iona l
radiography in the detection of bony
erosion around the tumour, especially
of the skull base. CT of the neck
performed at the same t ime helps
document involvement of cervical
lymph nodes.8 It also provides
information as to whether retropha-
ryngeal lymph nodes are affected,9 this
has been shown to be of prognostic
value in determining local tumour
control and d i s tan t metas tas is . 1 0
Magnetic resonance imaging (MRI)
besides defining the extent of tumour
involvement, has superior multiplanar
capability and better delineation of
tissue plane. (Figure 5) It can
differentiate tumour from inflamma-
tion and provides better recognition of
the exact extent of the disease but is
l im i t ed by its a b i l i t y to provide
information on bone erosion. Both CT
and MRI can each give precise
information on the extent of tumour
and are now both routinely used in the
planning of radiotherapy.
(Continued on page 276)
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Figure 4: Computed tomography showing the tumour in the nasopharynx
(T)
Figure 5: Magnetic resonance image in sagittal plane showing the
tumour in the nasopharynx (T) below the sphenoid sinus (S)
and involves upper part of nasal septum (N)
Treatment
Radiotherapy
As NPC is a radiosensi t ive
tumour, external radiotherapy is the
primary modality of treatment. The
results of therapy with radiation have
improved over the years because of
more precise staging of disease and
more refined techniques of delivering
the radiation. Overall 5 year survival
rates ranged from 70 to 85% for stage
I and 20 to 40% for stage IV.11-13
In view of the location of the
nasopharynx, the radiat ion beam
employed for the treatment of the
nasopharyngeal carcinoma has to pass
through nearby structures and this
contributes to the side effects of
radiotherapy. A frequent complaint is
dryness of mouth, which in its severe
form may affect the taste of food and
lead to dental caries. As the salivary
glands are also in the field of radiation,
xerostomia once developed will
progress and remain permanent.
Frequent fluid ingestion and the use of
artificial saliva may help to alleviate
symptoms.
With modification of techniques
of delivery of radiation energy some
complications may be avoided without
jeopardizing the eff icacy of the
radiation. The pituitary gland and the
skull base can be shielded and the
devastating complication of temporal
lobe necrosis avoided. With this
modif ica t ion , f requent ly quoted
neuroendoc r ine c o m p l i c a t i o n s
following radiotherapy may also be
reduced.14
Patients suffering from NPC are
particularly prone to develop serous
(Continued on page 278)
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otitis media, as the primary tumour in
the n a s o p h a r y n x may have a
mechanical effect on the function of
the Eustachian tube. Serous otitis
media may also develop af ter
radiotherapy and the radiation energy
may cause further Eustachian tube
dysfunction.15-16 Myringotomy and
insertion of a ventilation tube is
effective in releasing the collection of
fluid in the middle ear when serous
otitis media is detected prior to
radiotherapy. When the ventilation
t u b e s a re i n s e r t e d o n l y a f t e r
completion of radiotherapy then the
incidence of complications such as
otorrhoea and gradual decrease in
hearing are higher.17 As the inner ear
with the auditory cranial nerve are
wi th in the i r radia t ion f i e ld for
treatment of primary NPC, changes in
the nerve and the nearby brainstem
have been reported.18 A prospective
study of the effect of radiation on the
inner ear has also shown that 24% of
individuals developed sensorineural
hearing loss when examined at 30
months following radiotherapy. High
frequencies are affected more often
than the low frequency range and the
addition of chemotherapy does not
seem to affect the aural function.19
When the extent of tumour is
defined more precisely with better
imaging techniques and when more
efficient delivery of radiation energy
such as hyperfractionation is available,
then the results of radiotherapy for
NPC will improve further with fewer
undesired side effects.
Chemotherapy
Tradi t ional ly , pa t i en t s w i th
advanced locoregional diseases are
also treated w i th radio therapy.
Outcome in these patients both for
control of disease locoregionally and
systemically are not satisfactory.
Chemotherapy has been introduced in
an attempt to control distant metastasis
and to reduce tumour burden in the
nasopharynx before radiotherapy.
Prospec t ive r a n d o m i z e d t r i a l s
employing induction chemotherapy
showed no overall survival benefit20
but better disease free survival . 2 1
C o n c o m i t a n t c h e m o t h e r a p y to
eradicate distant metastasis also tends
to increase the cytotoxicity of radiation
towards the primary tumour. One
prospective study comparing radio-
therapy alone versus radiotherapy with
concomitant cisplatin followed by
three cycles of adjuvant cisplatin and
flurouracil showed a survival benefit in
favour of the chemotherapy group.22
More prospective studies are necessary
to establish the role of chemotherapy
in the management of NPC.
Surgery
Despite improvements in the
t r ea tmen t r e su l t s of NPC wi th
radiotherapy in recent years, some
patients will develop local or regional
recurrence after complet ion of
radiotherapy. Additional courses of
external radiotherapy may be useful
but a limiting factor is tolerance of
surrounding tissues to further doses of
radiation.
Surgical resection of either local
or regional recurrence has been shown
to yield satisfactory results.
Neck recurrence
Nasopharyngeal carcinoma has a
high propensity for metastasis to
cervical lymph nodes and thus the neck
Figure 6: Histological slide showing multiple tumour bearing lymph nodes (arrow) (haematoxylin and
eosin X 40)
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is routinely included in the irradiation
field. Despite such elective radio-
therapy, about 8% of patients suffer
| from recurrent disease in the cervical
I lymph nodes. Further irradiation of
these nodes controlled tumour in the
neck in 19% of patients23 while surgery
in the form of radical neck dissection
could achieve local tumour control in
66% of patients.24
Step serial whole organ sectioning
of the radical neck dissect ion
specimens showed that the tumour in
the cervical lymph nodes showed
extensive pathological features. There
was a six fold increase in lymph node
involvement in the specimens when
compared to clinical examination.
(Figure 6) Seventy per cent of tumour
in the nodes exhibited extracapsular
spread and in 30% of the specimens
tumour was found to be lying close to
the spinal accessory nerve or involving
neck muscle. In view of the aggressive
behaviour of tumour in the lymph
nodes, optimal treatment of cervical
nodal metas tas i s in NPC af ter
radiotherapy involves radical neck
dissection.25
Recurrence at the primary
site
1. Brachytherapy
Although NPC is radiosensitive,
in some patients the primary
tumour still persists or recurs
after radical doses of external
radiotherapy. For further radio-
therapy to be effective, the dose
has to be greater than 60 Gy. The
result ing radiation effect on
normal surrounding tissue may
produce serious long t e r m
sequelae such as neuro-endocrine
disturbances, poor non-verbal
memory recal l and even the
induc t ion of sarcoma in the
paranasal sinus.26
Brachytherapy with radioactive
gold grains has been employed.
When recurrent or persistent
tumour in the nasopharynx is 1 to
1.5cm in diameter. The gold
grains can be inserted into the
tumour under direct vision via the
spl i t palate approach w i t h a
special applicator.27 Morbidity
associated with the operation is
low and the probability of tumour
control in the nasopharynx was
at 5 years.28
2. Surgical resection
Between February 1989 and July
1997, in the Otorhinolaryngology
D e p a r t m e n t , Head & Neck
Division of the Department of
Surgery, The University of Hong
Kong Medical Centre, Queen
Mary Hospital, we have employed
an anterolateral (maxillary swing)
approach for the resection of
r e c u r r e n t n a s o p h a r y n g e a l
carcinoma in 48 patients. At
operation, resection margins were
subjected to f rozen sect ion
examinat ion. When all the
margins were nega t ive , the
resection was considered to be
curative. This was achieved in 45
patients and these form the basis
of the present study.
All patients received radical
external radiotherapy before
operation, the dosage ranged from
59.9 to 120 Gy (median 63.5 Gy).
The median disease-free interval
between the radiation treatment
and surgery group was 12 months.
All the 45 pa t ien ts underwent
n a s o p h a r y n g e c t o m y v i a t he
anterolateral (maxi l l a ry swing)
approach. The m a x i l l a was
swung la te ra l ly but remained
at tached to the anter ior cheek
f l a p to g a i n access to the
nasopharynx.29 (Figure 7) Mac-
roscopic tumour was removed
with at least a I cm margin. The
extent of resection thus comprised
the roof, posterior and the lateral
w a l l s of the n a s o p h a r y n x ,
including the Eustachian tube on
the side of the tumour . After
completion of the resection, the
whole osteocutaneous complex
was returned and fixed to the rest
o f the f a c i a l ske l e ton w i t h
miniplates and screws.30
All 45 pat ients survived the
operation and were discharged
from hospital . The follow-up
period of the group ranged from
6 to 76 months (med ian , 24
months). Facial wounds healed
primarily and they were able to
tolerate an oral diet on the third
postoperative day. All developed
some degree of trismus during the
first few months after operation.
Conservative treatment was
employed and trismus usual ly
improved with minimal functional
disability. A palatal fistula was
detected in ten patients (22%).
In one patient, the fistula was
closed surgically with a palatal
flap while in the other patients,
the f i s t u l a e were managed
conservatively with dental plates.
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Figure 7: Schematic computed tomography:
Upper: Osteotomies over the maxilla is
marked with dotted line
Lower: The maxilla attached to the
anterior cheek flap is swung
laterally to expose tumour in
the nasopharynx (arrow)
Figure 8: Post operative follow up pictures:
Upper: Left Weber Ferguson facial
scar is invisible at 18 months
after operation
Lower: Lip and palatal wound has
healed completely
At the time of assessment, ten
patients had developed local recurrent
tumour, three patients died of regional
d i sease and two from d i s t a n t
metastasis. Three patients died of
causes unrelated to the tumour. The
remaining 27 patients were alive and
free of disease. The 5-year actuarial
control of tumour in the nasopharynx
was 52% and the 5-year actuarial
survival of this group of patients was
43%, with a median survival of 53
months.
The anterolateral route to the
nasopharynx with the maxillary swing
approach provides wide exposure of
the whole nasopharynx and the parana-
sopharyngeal space. The operation is
not difficult and associated morbidity
is acceptable. (Figure 8) This
approach for nasopharyngectomy
should be employed whenever it is
considered appropriate. •
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